A new federal program, Medicare GLP-1 Bridge, is making expensive GLP-1 weight loss drugs more affordable for certain Medicare and Medicare Advantage beneficiaries. Starting Wednesday, eligible older Americans can access these medications for $50 a month. This temporary initiative, running until the end of 2027, marks the first time many older adults can have GLP-1s covered by insurance solely for weight loss. However, there are specific weight and health criteria, and those already receiving coverage for conditions like diabetes and sleep apnea are not eligible. Dr. Mehmet Oz, the administrator of the Centers for Medicare & Medicaid Services, expressed hope that the program will provide immediate financial relief and help gather data for potential long-term coverage solutions. He emphasized that the high cost of these drugs has been a significant barrier, which the program aims to address.
QUESTION: How might the availability of affordable weight loss medications impact the health and well-being of older adults in the long term?
GLP-1 weight loss drugs are now $50 a month for some Americans. Here’s who qualifies
